Reported about 13 hours ago
India and the US are nearing a transformative trade agreement aimed at boosting bilateral trade from $190 billion to $500 billion by 2030, with a focus on the pharmaceutical sector. As negotiations advance, India proposes tariff exemptions and technology access in response to potential US tariffs that threaten its generic drug industry, which supplies nearly half of US generics. Amid geopolitical tensions and Trump's trade policies, India's efforts to negotiate favorable terms highlight the importance of maintaining strategic ties and ensuring the stability of its pharmaceutical exports.
Source: YAHOO